Abata in the News Abata Therapeutics Appoints Ellen Cahir-McFarland, Ph.D., as Chief Scientific Officer Press Release December 7, 2022 Abata Therapeutics to Participate in Guggenheim’s 4th Annual Immunology and Neurology Day Press Release November 9, 2022 Samantha Singer Named as 2022 PharmaVoice 100 Honoree September 8, 2022 Abata Therapeutics to Present at Upcoming September Investor Conferences Press Release August 31, 2022 Abata Therapeutics to Participate in the Guggenheim I&I Spotlight Series – Treg-Based Therapies Press Release July 7, 2022 Abata Therapeutics to Present at Upcoming Investor Conferences Press Release June 2, 2022 Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer Press Release April 28, 2022 Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development Press Release April 6, 2022 Does It Matter Where You Locate Your Biopharma Anymore? Life Science Leader December 3, 2021 Treg engineers take aim at autoimmunity Nature Biotechnology November 9, 2021 Load More
